| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/07/2009 | WO2009058347A1 Aryl-substituted bridged or fused diamines as modulators of leukotriene a4 hydrolase |
| 05/07/2009 | WO2009058327A1 Cyclodextrin derivatives as potentiators for antibiotics |
| 05/07/2009 | WO2009058300A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto |
| 05/07/2009 | WO2009058267A2 Benzomorpholine derivatives and methods of use |
| 05/07/2009 | WO2009058261A1 Modulation of sleep with nr2b receptor antagonists |
| 05/07/2009 | WO2009058238A1 Substituted diazepan orexin receptor antagonists |
| 05/07/2009 | WO2009058216A1 Amine derivative compounds for treating ophthalmic diseases and disorders |
| 05/07/2009 | WO2009058120A1 Nicotinic acetylcholine receptor modulators |
| 05/07/2009 | WO2009058102A1 Methods and compounds for preventing and treating a tumour |
| 05/07/2009 | WO2009058076A1 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/07/2009 | WO2009058051A1 5-substituted indol-3-carboxylic acid derivatives exhibiting antiviral activity a method for the production and use thereof |
| 05/07/2009 | WO2009058005A2 Unit dosage for brain health |
| 05/07/2009 | WO2009057994A1 Unit dosage for brain health |
| 05/07/2009 | WO2009057982A1 Composition and method for preventing and treating immune-related disorder |
| 05/07/2009 | WO2009057827A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors |
| 05/07/2009 | WO2009057811A2 Heterocyclic compound and pharmaceutical composition thereof |
| 05/07/2009 | WO2009057795A2 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies |
| 05/07/2009 | WO2009057784A1 Heterocyclic compound |
| 05/07/2009 | WO2009057775A1 Anti-fatigue agent comprising amino acid composition |
| 05/07/2009 | WO2009057768A1 Anti-fungal agent and anti-bacterial agent |
| 05/07/2009 | WO2009057733A1 Novel indole derivative having anti-angiogenic activity |
| 05/07/2009 | WO2009057685A1 Pharmaceutical composition for treating overactive bladder |
| 05/07/2009 | WO2009057569A1 Film-coated preparation |
| 05/07/2009 | WO2009057139A2 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 05/07/2009 | WO2009057086A1 Novel r,r'-atracurium salts |
| 05/07/2009 | WO2009056990A2 Paliperidone polymorphs |
| 05/07/2009 | WO2009056983A1 New dha derivatives and their use as medicaments |
| 05/07/2009 | WO2009056980A1 Stabilized pediatric suspension of carisbamate |
| 05/07/2009 | WO2009056952A1 Geminal bisphosphonates, their preparation and their use in the field of oncology |
| 05/07/2009 | WO2009056886A1 Pyrimidine derivatives and their use as modulators of fgfr activity |
| 05/07/2009 | WO2009056885A1 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 05/07/2009 | WO2009056881A1 Chemical compounds 313 |
| 05/07/2009 | WO2009056851A1 Compositions for treating parkinson's disease |
| 05/07/2009 | WO2009056849A1 Treatment of spinal cord injury |
| 05/07/2009 | WO2009056818A1 Novel antiretroviral combination |
| 05/07/2009 | WO2009056811A2 Tetrahydrobenzothiazole derivatives with dopamine receptor activity |
| 05/07/2009 | WO2009056805A1 Medicaments |
| 05/07/2009 | WO2009056754A2 Use of econazole or salts thereof for treating acne |
| 05/07/2009 | WO2009056737A2 Novel nacl salt substitute, use thereof and products containing same |
| 05/07/2009 | WO2009056707A2 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/07/2009 | WO2009056693A1 Novel derivatives of n, n'- 2, 4-dianilinopyrimidines, preparation thereof as medicaments pharmaceutical compositions and in particular as ikk inhibitors |
| 05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | WO2009056671A1 Method for inhibiting angiogenesis or for treatment of cancer |
| 05/07/2009 | WO2009056660A1 Novel chemotherapeutic agents for cancer treatment |
| 05/07/2009 | WO2009056632A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 05/07/2009 | WO2009056625A1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | WO2009056617A2 4,4-disubstituted piperdines as renin inhibitors |
| 05/07/2009 | WO2009056600A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/07/2009 | WO2009056582A1 Novel compounds |
| 05/07/2009 | WO2009056556A1 Substitute 1, 6-naphthyridines for use as scd inhibitors |
| 05/07/2009 | WO2009056522A1 Topical composition |
| 05/07/2009 | WO2009056434A1 Combination products for treating cancer |
| 05/07/2009 | WO2009056321A1 Controlled activation of non-ltr retrotransposons in mammals |
| 05/07/2009 | WO2009056292A1 Osmolyte-containing preparation for use in case of dry mucous membranes |
| 05/07/2009 | WO2009056266A2 Candesartan cilexetil |
| 05/07/2009 | WO2009056256A1 Use of megestrol acetate having improved solubility for the treatment of cancer cachexia |
| 05/07/2009 | WO2009056255A1 Dough composition |
| 05/07/2009 | WO2009056212A1 Compositions containing resveratrol and pectin |
| 05/07/2009 | WO2009056146A1 Pharmaceutical composition comprising gaboxadol and an inhibitor of patl or oat |
| 05/07/2009 | WO2009056070A1 Ligustrazine aromatic acid ether derivative, its preparation method, pharmaceutical composition, and application |
| 05/07/2009 | WO2009056029A1 Purification method of pemetrexed salts,sodium salts and disodium salts |
| 05/07/2009 | WO2009055937A1 Altered n-cadherin processing in tumor cells by furln and proproteln convertase 5a (pc5a) |
| 05/07/2009 | WO2009055935A1 Hyperbranched polyglycerol for improving heart function |
| 05/07/2009 | WO2009055933A1 Medium-chain length fatty acids and glycerides as nephroprotection agents |
| 05/07/2009 | WO2009055932A1 Substituted phenylpropionic acids as stimulators of hematopoiesis and erythropoiesis |
| 05/07/2009 | WO2009055925A1 Enhanced nsaid formulations |
| 05/07/2009 | WO2009055923A1 Ingestible film composition |
| 05/07/2009 | WO2009055917A1 Inhibitors of histone deacetylase |
| 05/07/2009 | WO2009055869A1 Aryloxy amine compounds and their use as sodium channel modulators |
| 05/07/2009 | WO2009055867A1 Treatment of metabolic disease |
| 05/07/2009 | WO2009055864A1 Methods and compositions for regulating airway tissue remodelling |
| 05/07/2009 | WO2009055863A1 Desferrioxamine conjugates, derivatives and analogues |
| 05/07/2009 | WO2009055859A1 Transdermal delivery system for hormones and steroids |
| 05/07/2009 | WO2009055854A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | WO2009039420A9 Methods and compositions for treating neuronal death mediated ocular diseases |
| 05/07/2009 | WO2009039388A3 Compositions and methods for detecting and treating ophthalmic disorders |
| 05/07/2009 | WO2009039262A3 Steroid containing ophthalmic drug delivery systems |
| 05/07/2009 | WO2009039218A3 Compositions and methods for treating inflammation and inflammation-related disorders by plectranthus amboinicus extracts |
| 05/07/2009 | WO2009039157A3 Orlistat pharmaceutical formulations |
| 05/07/2009 | WO2009038707A9 Cancer-testis gene silencing agents and uses thereof |
| 05/07/2009 | WO2009038289A3 Pharmaceutical compositions for preventing or treating fibrosis |
| 05/07/2009 | WO2009037707A3 N-phenyl anthranilic acid derivatives and uses thereof |
| 05/07/2009 | WO2009037001A3 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 05/07/2009 | WO2009036753A3 Novel pharmaceuticals, method for the production thereof and use thereof in medical therapy |
| 05/07/2009 | WO2009036712A3 Dosage form containing tramadol with controlled 24-hour release and a process for manufacturing the same |
| 05/07/2009 | WO2009036407A3 Compositions and methods for regulating cellular protection |
| 05/07/2009 | WO2009036341A3 Compositions and methods relating to hiv protease inhibition |
| 05/07/2009 | WO2009035553A3 Analogs of tetramic acid |
| 05/07/2009 | WO2009035534A3 Treatment of ischemic eye disease by the systematic pharmaceutical activation of hypoxia inducible factor (hif) |
| 05/07/2009 | WO2009035265A3 Calcium phosphate microspheres drug delivery system and process for preparing the same |
| 05/07/2009 | WO2009033489A3 Selective pacl inhibitors for use in the treatment of migraine and headaches |
| 05/07/2009 | WO2009032896A3 Resveratrol ferulate compounds, compositions containing the compounds, and methods of using the same |
| 05/07/2009 | WO2009031819A3 Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient |
| 05/07/2009 | WO2009031051A9 Stabilized anthocyanin compositions |
| 05/07/2009 | WO2009030952A3 Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway |
| 05/07/2009 | WO2009029888A3 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
| 05/07/2009 | WO2009027786A3 Matrix dosage forms of varenicline |
| 05/07/2009 | WO2009026176A3 Antiinfective flavononol compounds and methods of use thereof |
| 05/07/2009 | WO2009024287A3 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof |
| 05/07/2009 | WO2009023320A3 Modular linkers for conjugation of organic substances to substantially inorganic substances and methods of manufacture and use thereof |